GRN and neoplasm: Using biochemical experiments and GRN analysis, we propose SOX2 as an upstream regulator of NTRK2, targeting the PI3K pathway to control cell growth, while NTRK2 may play a pivotal role in tumor metastasis through interaction with E-cad.